[ Price : $8.95]
Pfizer says a recent Phase 3 study with tasocitinib in rheumatoid arthritis patients met two primary endpoints.[ Price : $8.95]
Medco Research Institute says a pharmacy-based outreach program boosts consent for and participation in genetic testing to improve...[ Price : $8.95]
FDA approves a Bristol-Myers Squibb NDA for Kombiglyze XR (saxagliptin and metformin extended-release) for treating Type 2 diabete...[ Price : $8.95]
In its efforts to harmonize data standards for regulatory purposes, FDA principal deputy commissioner Joshua Sharfstein denies the...[ Price : $8.95]
FDA approves Eli Lillys Cymbalta (duloxetine HCl) for managing chronic musculoskeletal pain.[ Price : $8.95]
FDA sends Carestream Health an approval letter for its CareStream DirectView CR, a high-resolution computed radiography system for...[ Price : $8.95]
Federal Register Final rule: FDA reclassifies the full-field digital mammography system from Class 3 to Class 2 with a guidance do...[ Price : $8.95]
Federal Register Notice: FDA releases a special controls guidance on full-field digital mammography system.